1. Skip to content
Posted on

Mesothelioma Articles in Current Treatment Options in Oncology

A number of articles on malignant mesothelioma have recently appeared in Current Treatment Options in Oncology, an important medical journal that features reports on the latest in oncology medicine. The journal was “developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding number of treatment options published in their subject,” so it features case reports and detailed descriptions of the latest treatments and other research on individual cancers.

The recently-published articles on mesothelioma encompass a variety of important topics in mesothelioma research, including the latest data on pleural mesothelioma and peritoneal mesothelioma, as well as descriptions of cutting-edge mesothelioma treatments and diagnostic procedures.

We will be publishing individual summaries of the following articles within the next week:

  • “Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis” provides an overview of the latest research on the biological factors responsible for mesothelioma genesis. One of the authors of the article, Michele Carbone, MD, PhD, is an internationally-regarded researcher on mesothelioma.
  • “Diagnosis, Staging, and Surgical Treatment of Malignant Pleural Mesothelioma” is an article written by physicians at Memorial Sloan – Kettering Cancer Center in New York City, one of the country’s most well-regarded cancer centers. The article features the latest information on mesothelioma diagnosis and a detailed description of the current mesothelioma staging system. It also provides an overview of the main surgical treatments for mesothelioma.
  • “Systemic Treatments for Mesothelioma: Standard and Novel” describes how chemotherapy is used for the treatment of mesothelioma and it provides detailed information regarding combination therapy using pemetrexed and cisplatin, which is the chemotherapy standard of care for treatment of pleural mesothelioma, as well as information on newer agents that are being investigated for treatment of the disease.

More articles by

Nancy Meredith is a blog and web content writer with more than 20 years of professional experience in the Information Technology industry. She has been writing about Mesothelioma for 4 years. Follow Nancy on Google+

Comments are closed.